Fremanezumab (Anti-CALCA / CGRP)
Fremanezumab (Anti-CALCA / CGRP) is a humanized IgG2a monoclonal antibody that selectively and potently targets calcitonin gene-related peptide (CGRP). Fremanezumab has the potential for chronic migraine research.. MW: 145.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2791 |
Sku # | A2791-1mg |
Pricing | 1mg, $370.00 |